Stability of Six Drugs in Elneopa NF Infusion after Passing through Infusion Line

  • Kumagai Takefumi
    Pharmacy Co. Ltd.
  • Yamashita Jun
    Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Narahara Naoko
    Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Sato Eiji
    Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Kihira Yoshitaka
    Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Fujimura Yoshino
    Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Kojima Eijiro
    Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Ogawa Shojiro
    Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Date Yuko
    Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
  • Inoue Hirofumi
    Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University

Bibliographic Information

Other Title
  • エルネオパNF輸液中に混注された6種薬剤の輸液ライン通過後の濃度変化に関する検討

Description

<p>Elneopa NF No. 1 and No. 2 infusions are total parenteral nutrition solutions packaged in four-chambered infusion bags. When Elneopa NF infusions are used as home parenteral nutrition, various drugs are co-injected into the infusion bags to treat patient symptoms. This study evaluated the stability of six drugs, including famotidine, scopolamine butylbromide, furosemide, bromhexine hydrochloride, betamethasone sodium phosphate, and metoclopramide hydrochloride, in the Elneopa NF infusion solutions after passing through the infusion line for 24 hours. We observed no therapeutically significant reductions in famotidine, scopolamine butylbromide, furosemide, betamethasone sodium phosphate, and metoclopramide hydrochloride concentrations in Elneopa NF No. 1 and No. 2 after passing through the infusion line. However, we observed a significant decrease in bromhexine hydrochloride concentration in Elneopa NF No. 1 and No. 2 after passing through the infusion line. Therefore, when bromhexine hydrochloride is co-injected into Elneopa NF, the expected therapeutic effect may not be obtained. Also, it was suggested that there was no conversion to insoluble particulate matter affecting their concentration by the co-injection of 6 drugs. The results of this study provide valuable information on total parenteral nutrition.</p>

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1390581412164022016
  • DOI
    10.32160/yakkyoku.nt.2023-0016
  • ISSN
    24343242
    18843077
  • Text Lang
    ja
  • Article Type
    journal article
  • Data Source
    • JaLC
    • KAKEN
  • Abstract License Flag
    Disallowed

Report a problem

Back to top